Acadian Asset Management
BLPH

Acadian Asset Management’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Acadian Asset Management’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-199,600
Closed -$6K – 1863
2023
Q4 		$6K Sell
199,600
-183,578
-48% -$64.1K ﹤0.01% 1635
2023
Q3 		$152K Buy
383,178
+117,925
+44% +$58.1K ﹤0.01% 1238
2023
Q2 		$182K Buy
+265,253
New +$1.71M ﹤0.01% 1293

Acadian Asset Management's BLPH Position: Q1 2024 in Review

Acadian Asset Management sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q1 2024, closing a stake of 199,600 shares — an estimated $6K sold.

Acadian Asset Management first reported a position in BLPH in Q2 2023 and held it in 3 quarters. The position peaked at $182K in Q2 2023. 0 funds tracked by Wall St. Rank hold BLPH as of Q1 2024.

  • Acadian Asset Management reported no remaining Bellerophon Therapeutics, Inc. position as of Q1 2024 after selling out during the quarter.
  • Acadian Asset Management sold 199,600 Bellerophon Therapeutics, Inc. shares in Q1 2024, an estimated $6K.
  • Acadian Asset Management first reported a position in Bellerophon Therapeutics, Inc. in Q2 2023 and held it in 3 quarters.
  • Acadian Asset Management's Bellerophon Therapeutics, Inc. position peaked at $182K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q1 2024.

Based on Acadian Asset Management's 13F filing for Q1 2024, filed 10 May 2024.